3656 results for «335»
3656 results
When complications storm through the cathlab: part 2
07 Dec 2023 – From GulfPCR-GIM 2023
The continuation of this session focuses on complications that may occur during PCI in the cathlab. Through the lens of these cases, be prepared about what type of complications one might face during PCI, and get updates on the latest guidelines and tools developed for emergencies.
Stuck between a rock and a hard place: when calcium is the enemy!
07 Dec 2023 – From GulfPCR-GIM 2023
Have you ever wondered what tools and techniques to use when faced with calcified lesions? Watch this session to discover various cases of severely calcified lesions: the use of IVUS guidance and rota-cut when faced with tough calcium, PCI of a stubborn fibrotic coronary lesion, as...
Challenging CTO interventions: part 3
07 Dec 2023 – From GulfPCR-GIM 2023
In this session, broaden your knowledge in CTO treatment by exploring these diverse cases: delve into the complexities of managing double CTO lesions with ACS, gain insights into the ambiguous ostium antegrade CTO, and explore effective techniques such as the semi stent crush technique for closing...
Challenging structural interventions: part 2
07 Dec 2023 – From GulfPCR-GIM 2023
In this session, discover challenging structural interventions cases, such as the treatment of a large perm catheter related right atrial massa, transcatheter tricuspid valve-in-valve, post-TAVI severe hypotension, and more!
Challenging STEMI scenarios: part 2
07 Dec 2023 – From GulfPCR-GIM 2023
In this session, delve into intricate STEMI cases, featuring presentations on the challenges of primary PCI for left main, the significance of IVUS in STEMI patients during primary PCI, a compelling exploration of myocardial infarction in an anomalous coronary artery, and much more!
Tailored approaches to complex bifurcation PCI: part 2
07 Dec 2023 – From GulfPCR-GIM 2023
Consult this session to discover various complex PCI bifurcation cases, and learn more about the step by step approach on how to treat an ostial LAD lesion, and relevant procedures, such as the cutting balloon angioplasty, CABG or the trifurctional intervention.
Complex left main PCI: ancillary tools for safer interventions
07 Dec 2023 – From GulfPCR-GIM 2023
Consult this session to discover complex left main PCI cases, such as a severe stenosis in the distal left main bifurcation and differentiating atherosclerotic lesions from catheter-induced vasospasm, explore effective techniques such as imaging-guided optimisation for complex angioplasty, and more!
When complications storm through the cathlab: part 3
07 Dec 2023 – From GulfPCR-GIM 2023
These slides focus on complications that may occur during PCI in the cathlab. Through the lens of this case, be prepared about what type of complications one might face during PCI, and get updates on the latest guidelines and tools developed for emergencies.
Legal notice
19 Oct 2018
Updated - August 22nd, 2023
AsiaPCR 2018: General Terms and conditions of sale
MASTER-DAPT: “the MASTER of high-bleeding risk trials”
28 Aug 2021
Marco Valgimigli (Lugano, Switzerland) presented the results of the MASTER DAPT trial on Saturday, August 28, in a Hot Line session of the ESC Congress 2021. Luis G. Ortega-Paz provides his PICOT & SWOT analysis of this study.
Author
ALL-RISE: A large-scale, global randomized trial of coronary physiology derived from conventional angiography compared with an invasive pressure wire-based approach to guide PCI
28 Mar 2026
Mirvat Al Asnag provides her take on the ALL-RISE randomised trial presented by Ajay J. Kirtane at ACC.26 in New Orleans.
Author
Europa Group's General Terms and Conditions of Sale
12 Apr 2024
Ref 02P - Updated June 2024
Harmonising optimal strategy for treatment of coronary artery diseases – bleeding risk: HOST-BR
29 Mar 2025
Daniele Giacoppo and Nicola Ammirabile provide their take on the main results of the HOST-BR trial, presented by Hyo-Soo Kim at ACC.25 in Chicago.
Author
Author
The AQUATIC trial: Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation
01 Sep 2025
Chiara De Biase provides her take on the results of AQUATIC presented by Martine Gilard at ESC Congress 2025 in Madrid.
Author
![The AQUATIC trial [Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation: Rationale for and design of the AQUATIC double-blind randomized trial]](https://www.pcronline.com/var/pcrov3/storage/images/pcronline/news/congress-coverages/esc/2025/aquatic-trial-quitting-versus-using-aspirin-therapy-patients-stabilized-cad-stenting-long-term-oral-anticoagulation/27448089-9-eng-GB/The-AQUATIC-trial-Assessment-of-quitting-versus-using-aspirin-therapy-in-patients-with-stabilized-coronary-artery-disease-after-stenting-who-requi_image_responsive_6.jpg)
NEO-MINDSET: Early withdrawal of aspirin after percutaneous coronary intervention for acute coronary syndrome
02 Sep 2025
Daniele Giacoppo reports and provides his perspective on the main results of the ambitious NEOMINDSET trial, presented by Pedro Lemos from the Hospital Israelita Albert Einstein, São Paulo, Brazil, during a Late Breaking Trials session at the ESC Congress 2025 in Madrid, and simultaneously published in the New...
Author
